Categories
Archives
Receive Email Updates

-


-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me

Warren D. Woessner
Pages
Archives
Category Archives: Patent Eligible Subject Matter
Revised 2014 Interim Guidance on Patent Subject Matter Eligibility Released by PTO
On Monday, December 15th, the Patent Office released revised “Guidance” on the evaluation of subject matter patent-eligibility under s. 101. (A copy is available at the end of this post.) The “Guidance” is an attempt to unify the analyses that … Continue reading
Posted in Patent Eligible Subject Matter
Tagged biotechnology, intellectual property, ip, IP law tools, Patent Law, patents, USPTO, Warren Woessner
Leave a comment
Federal Circuit flips on Ultramercial v. WildTangent
After two trips to the Supreme Court and two remands, the Federal Circuit considered Ultramercial v. WildTangent for the third time—this time with Alice in hand—and ruled that the district court properly dismissed Ultramercial’s suit as failing to state a … Continue reading
C.I.T. v. Hughes Comm. – Survival Guide for Software?
On November 3, 2014, in Cal. Inst. Of Tech. v. Hughes Communications., 2014 U.S.. Dist. LEXIS 156763 (C.D. Cal. 2014), Judge Mariana Pfaelzer penned the most thorough defense of software claims attacked under s. 101 that I have seen since … Continue reading
Genetic Technologies v. Bristol Myers – 101 At Work
In the recent memorandum opinion, the court invalidated claim 1 of U.S. Pat. No. 5,612,179, owned by Genetic Technologies, Ltd., as “impermissibly [claiming] a natural phenomenon.” (Genetic Technologies, Ltd. v. Bristol-Myers Squibb Company, C.A. No. 12-394-LPS (D. Delaware, Oct. 30, … Continue reading
Posted in Patent Eligible Subject Matter
Tagged Federal Circuit, Genetic Technologies, intellectual property, ip, Mayo, Myriad, Patent Law, patents, Warren Woessner
1 Comment
